Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury

Efficient in vivo delivery of anti-inflammatory proteins to modulate the microenvironment of an injured spinal cord and promote neuroprotection and functional recovery is a great challenge. Nucleoside-modified messenger RNA (mRNA) has become a promising new modality that can be utilized for the safe and efficient delivery of therapeutic proteins. Here, we used lipid nanoparticle (LNP)-encapsulated human interleukin-10 (hIL-10)-encoding nucleoside-modified mRNA to induce neuroprotection and functional recovery following rat spinal cord contusion injury. Intralesional administration of hIL-10 mRNA-LNP to rats led to a remarkable reduction of the microglia/macrophage reaction in the injured spinal segment and induced significant functional recovery compared to controls. Furthermore, hIL-10 mRNA treatment induced increased expression in tissue inhibitor of matrix metalloproteinase 1 and ciliary neurotrophic factor levels in the affected spinal segment indicating a time-delayed secondary effect of IL-10 5 d after injection. Our results suggest that treatment with nucleoside-modified mRNAs encoding neuroprotective factors is an effective strategy for spinal cord injury repair.

[1]  A. Nógrádi,et al.  The use of a detailed video-based locomotor pattern analysis system to assess the functional reinnervation of denervated hind limb muscles , 2021, Journal of Neuroscience Methods.

[2]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[3]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[4]  A. Nógrádi,et al.  Grafted human induced pluripotent stem cells improve the outcome of spinal cord injury: modulation of the lesion microenvironment , 2020, Scientific Reports.

[5]  Ronghan Liu,et al.  Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy , 2020, Oxidative medicine and cellular longevity.

[6]  D. Weissman,et al.  A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Ying Peng,et al.  TIMP1 preserves the blood–brain barrier through interacting with CD63/integrin β1 complex and regulating downstream FAK/RhoA signaling , 2020, Acta pharmaceutica Sinica. B.

[8]  A. Nógrádi,et al.  Neuroectodermal Stem Cells Grafted into the Injured Spinal Cord Induce Both Axonal Regeneration and Morphological Restoration via Multiple Mechanisms , 2019, Journal of neurotrauma.

[9]  H. Okano,et al.  The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury , 2019, Scientific Reports.

[10]  W. Murphy,et al.  Sustained interleukin-10 delivery reduces inflammation and improves motor function after spinal cord injury , 2019, Journal of neuroinflammation.

[11]  Hao Yin,et al.  Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  I. Sahu,et al.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  C. Rudolph,et al.  Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  S. Karimi-Abdolrezaee,et al.  Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms , 2019, Front. Neurol..

[15]  U. Şahin,et al.  A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA , 2019, Molecular therapy. Nucleic acids.

[16]  K. Kaur,et al.  mRNA-Based Protein Replacement Therapy for the Heart , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  I. Marriott,et al.  The Interleukin-10 Family of Cytokines and Their Role in the CNS , 2018, Front. Cell. Neurosci..

[18]  Brian J Cummings,et al.  Local Immunomodulation with Anti-inflammatory Cytokine-Encoding Lentivirus Enhances Functional Recovery after Spinal Cord Injury. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  D. Weissman,et al.  mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.

[20]  M. Fehlings,et al.  Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury , 2017, F1000Research.

[21]  N. Matsumoto,et al.  Intravenous infusion of adipose-derived stem/stromal cells improves functional recovery of rats with spinal cord injury. , 2017, Cytotherapy.

[22]  M. Fehlings,et al.  Enabling Technologies for Cell-Based Clinical Translation Concise Review : Bridging the Gap : Novel Neuroregenerative andNeuroprotective Strategies in Spinal Cord Injury , 2016 .

[23]  M. Amiji,et al.  Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles , 2015, Scientific Reports.

[24]  D. Weissman,et al.  Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[25]  M. Fang,et al.  Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model , 2013, Front. Neuroanat..

[26]  K. G. Rajeev,et al.  Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  S. Ortega‐Gutiérrez,et al.  Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery , 2012, PloS one.

[28]  S. Whittemore,et al.  Transplantation of Ciliary Neurotrophic Factor-Expressing Adult Oligodendrocyte Precursor Cells Promotes Remyelination and Functional Recovery after SpinalCord Injury , 2010, The Journal of Neuroscience.

[29]  K. Arai,et al.  Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. , 2009, Journal of neurotrauma.

[30]  Hiroki Kato,et al.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  R. Frausto,et al.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. , 2006, The American journal of pathology.

[32]  Houping Ni,et al.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.

[33]  Z. Werb,et al.  Blood‐spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing , 2003, Journal of neuroscience research.

[34]  R. Yezierski,et al.  Neuroprotective Effects of Interleukin-10 Following Excitotoxic Spinal Cord Injury , 1999, Experimental Neurology.

[35]  D. Basso,et al.  A sensitive and reliable locomotor rating scale for open field testing in rats. , 1995, Journal of neurotrauma.

[36]  A. Wittwer,et al.  Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in rat. , 1994, The Journal of clinical investigation.

[37]  Ravindra,et al.  Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model. , 2020 .

[38]  S. Rogers,et al.  Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. , 1999, Journal of immunology.